Processed ICSRs with full narratives
A set of individual case safety reports worked end to end, with narratives written to a defensible standard.
Pharmacovigilance · Nine months · Next cohort October 2026
Most training ends the day the certificate arrives, which is when the harder part begins. This one runs for nine months: ten weeks building a pharmacovigilance portfolio, then six months of applications, positioning and introductions with someone working the search alongside you.
Enrolment closes in
CPD accreditation submitted to The CPD Standards Office, Provider Number 51119. 14-day cooling-off period under the Consumer Contracts Regulations 2013.
A hiring manager filling a drug safety role is not testing whether you understand pharmacology. That much is assumed. They are working out something narrower: whether you can take an incoming report, decide what is reportable and by when, write a narrative that would hold up under inspection, and recognise the point at which a pattern becomes a signal.
None of that is visible in a degree, and none of it is visible in a certificate. It only becomes visible in the work itself. Which is why the gap most people are stuck in is not a knowledge gap. It is an evidence gap.
A certificate proves you studied. A portfolio proves you can do the job.
Six areas, taught to the standard the industry actually holds people to.
The history, definitions and minimum dataset that underpin every case you will ever touch.
How PV regulation compares across ten jurisdictions: EU, UK, US, Canada, Australia, Japan, India, Nigeria, Ghana and South Africa.
A case end to end, from the reporting clock to a narrative you could defend.
Applying GDPR, HIPAA and PIPEDA correctly to real case scenarios, not in the abstract.
Running disproportionality analysis, and knowing the point at which a signal has to be escalated.
The QPPV role, the safety master file, and what inspectors genuinely look for.
Three pieces of evidence you can put in front of a hiring manager. This is the part that changes the conversation.
A set of individual case safety reports worked end to end, with narratives written to a defensible standard.
Disproportionality analysis run properly, with your reasoning documented and your escalation decision justified.
The integrated benefit-risk analysis. Regulators read this section most closely, and very few people arrive able to write one.
Your clinical experience described in the language UK recruiters actually search for, your profile set up to be found, and the portfolio attached to both.
The regulatory architecture, the minimum dataset, and how the UK system sits against the nine other jurisdictions you may have trained in.
You process real-format cases under time pressure, with your narratives reviewed and returned. This is where the portfolio gets built.
Disproportionality analysis, your PBRER section, then your CV and profile rebuilt around what you have just produced.
Six months of working your job search alongside you. It is half of what this programme is, so it has its own section below.
Months 3 to 9
Learning pharmacovigilance and getting hired in pharmacovigilance are two different projects. Most training only does the first one, and leaves you at the certificate. Here is what the second half actually consists of.
Not tidied. Rebuilt around the terms pharma recruiters actually search on, so you appear in results you are currently invisible to.
You send me the role and your application. I tell you whether it is worth applying to and what is weak in it, before you send it rather than after it is rejected.
Run properly, with the technical questions you will actually be asked about case processing, causality and the reporting clock.
I put your evidence in front of the employers and recruiters I know are hiring. This is the part you cannot do for yourself from the outside.
Your profile visible to hiring employers with your portfolio evidence attached, rather than a CV sitting in a folder.
Not a single session. Six months of someone working the search with you, through the rejections and the near-misses as well as the offers.
From the next cohort, this six months costs £250 a month on top of the course fee. The October cohort gets all of it included.
I am Elfrida. I trained as a pharmacist, moved into pharma, and spent eleven years inside the industry watching qualified people get filtered out of roles they could already do.
This programme is the thing I wish had existed when I was working out how the UK system actually decides who gets shortlisted. It is built backwards from what employers test for, not forwards from what is easy to teach.
BPharm · MSc, King’s College London · MBA · Eleven years in pharma · Founder, PharmaTech Careers
Places are capped at 12. The cohort is small because I am personally working alongside each person on their job search, and that only works with small numbers.
This is the first time the programme runs, which means you get the version of it where the person who built it is still in the room with you.
Behind it: eleven years in pharma, a BPharm, an MSc from King's College London, an MBA, and a curriculum built backwards from what UK employers actually test for.
It is also the last cohort at this price. From January, the ten weeks and the mentorship are priced separately. What you get does not change, only what it costs.
Nine months. Ten weeks of training, six months of getting you in front of employers.
Paid in full, or spread over monthly instalments at checkout.
Both halves are included for this cohort. From January they are priced separately.
Places capped at 12. Cohort begins October 2026.
Because it is the first one. From the next cohort, the ten weeks and the six months of mentorship are priced separately, at £1,500 and £250 a month. This cohort gets both for £1,500, in exchange for being the group I build the track record with.
It is in progress. The programme has been submitted to The CPD Standards Office under Provider Number 51119, and the 49 CPD hours reflect the taught content as submitted.
Six months of working on your job search together. Your LinkedIn rebuilt so recruiters find you, your applications reviewed before they go out, mock interviews, and your portfolio put in front of employers and recruiters who are hiring. That support runs for six months, or until you are placed.
Around six hours during the ten taught weeks, including casework. The six months after that are lighter and fit around applying: reviews, interview prep and check-ins as you need them. Most people here are working full time, and material stays available for the full year.
No. Most UK pharmacovigilance roles do not require it, which is one of the main reasons this route is open to overseas-qualified professionals.
You have a 14-day cooling-off period under the Consumer Contracts Regulations 2013 from the date you enrol.
Yes. Your audit fee comes off the programme price if you enrol within seven days of your call. Use the code you were given at checkout.
Email hello@pharmatechcareers.co.uk with a little about your background and I will let you know honestly whether it suits you.
The Talent Directory is open to any qualified healthcare professional. Upload your CV and your profile becomes visible to employers and recruiters who are hiring. It is free, and you do not need to be on the programme.
Ten weeks of training, six months of the job search done with you. Places are capped at 12 and the cohort begins October 2026.
Enrol now — £1,50014-day cooling-off period applies.